Global Infectious Disease Rapid Diagnostics Testing Market- By Product (Over-the-Counter [OTC] Rapid Test Product and Professional Rapid Test Product), By Application (Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others), and End User (Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2020-2027.

Global Infectious Disease Rapid Diagnosis Testing Market
Report Content
1.	Research Strategic Development
1.1.	Market Modelling
1.2.	Product Analysis
1.3.	Market Trend and Economic Factors Analysis
1.4.	Market Segmental Analysis
1.5.	Geographical Mapping
1.6.	Country Wise Segregation
2.	Research Methodology
2.1.	Identification of Target Market
2.2.	Data Acquisition 
2.3.	Refining of Data/ Data Transformations
2.4.	Data Validation through Primary Techniques
2.5.	Exploratory Data Analysis
2.6.	Graphical Techniques/Analysis
2.7.	Quantitative Techniques/Analysis
2.8.	Visual Result/Presentation 
3.	Executive Summary
4.	Market Insights
4.1.	Economic Factor Analysis 
4.1.1.	Drivers
4.1.2.	Trends
4.1.3.	Opportunities
4.1.4.	Challenges
4.2.	Competitors & Product Analysis
4.3.	Regulatory Framework
4.4.	Company market share analysis, 2019
4.5.	Porter's Five forces analysis
4.6.	New Investment Analysis
4.7.	PESTEL Analysis
5.	Global Infectious Disease Rapid Diagnosis Testing Market Overview
5.1.	Market Size & Forecast, 2016-2027
5.1.1.	Demand
5.1.1.1.	By Value (USD Million)
5.2.	Market Share & Forecast, 2016-2027
5.2.1.	By Product
5.2.1.1.	Over-the-Counter (OTC) Rapid Test Product
5.2.1.2.	Professional Rapid Test Product
5.2.2.	By Application
5.2.2.1.	Infectious Disease
5.2.2.2.	Cardiology
5.2.2.3.	Oncology
5.2.2.4.	Pregnancy & Fertility
5.2.2.5.	Toxicology
5.2.2.6.	Glucose Monitoring
5.2.2.7.	Others
5.2.3.	By End-use
5.2.3.1.	Hospital & Clinic
5.2.3.2.	Diagnostic Laboratory
5.2.3.3.	Home Care
5.2.3.4.	Others
5.2.4.	By Region
5.2.4.1.	Europe
5.2.4.2.	North America
5.2.4.3.	Asia Pacific
5.2.4.4.	South America 
5.2.4.5.	Middle East & Africa 
6.	Europe Infectious Disease Rapid Diagnosis Testing Market Overview
6.1.	Europe Infectious Disease Rapid Diagnosis Testing Size & Forecast, 2016-2027
6.1.1.	Demand
6.1.1.1.	By Value (USD Million)
6.2.	Europe Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2027
6.2.1.	By Product
6.2.1.1.	Over-the-Counter (OTC) Rapid Test Product
6.2.1.2.	Professional Rapid Test Product
6.2.2.	By Application
6.2.2.1.	Infectious Disease
6.2.2.2.	Cardiology
6.2.2.3.	Oncology
6.2.2.4.	Pregnancy & Fertility
6.2.2.5.	Toxicology
6.2.2.6.	Glucose Monitoring
6.2.2.7.	Others
6.2.3.	By End-use
6.2.3.1.	Hospital & Clinic
6.2.3.2.	Diagnostic Laboratory
6.2.3.3.	Home Care
6.2.3.4.	Others
6.2.4.	By Country
6.2.4.1.	Germany
6.2.4.2.	UK
6.2.4.3.	France
6.2.4.4.	Italy
6.2.4.5.	Rest of Europe
6.2.5.	Company Market Share (Top 3-5)
6.2.6.	Economic Impact Study on Europe Infectious Disease Rapid Diagnosis Testing Market 
7.	North America Infectious Disease Rapid Diagnosis Testing Market Overview
7.1.	North America Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2027
7.1.1.	Demand
7.1.1.1.	By Value (USD Million)
7.2.	North America Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2027
7.2.1.	By Product
7.2.1.1.	Over-the-Counter (OTC) Rapid Test Product
7.2.1.2.	Professional Rapid Test Product
7.2.2.	By Application
7.2.2.1.	Infectious Disease
7.2.2.2.	Cardiology
7.2.2.3.	Oncology
7.2.2.4.	Pregnancy & Fertility
7.2.2.5.	Toxicology
7.2.2.6.	Glucose Monitoring
7.2.2.7.	Others
7.2.3.	By End-use
7.2.3.1.	Hospital & Clinic
7.2.3.2.	Diagnostic Laboratory
7.2.3.3.	Home Care
7.2.3.4.	Others
7.2.4.	By Country
7.2.4.1.	US
7.2.4.2.	Canada
7.2.4.3.	Mexico
7.2.5.	Company Market Share (Top 3-5)
7.2.6.	Economic Impact Study on North America Infectious Disease Rapid Diagnosis Testing Market 
8.	Asia Pacific Infectious Disease Rapid Diagnosis Testing Overview
8.1.	Asia Pacific Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2027
8.1.1.	Demand
8.1.1.1.	By Value (USD Million)
8.2.	Asia Pacific Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2027
8.2.1.	By Product
8.2.1.1.	Over-the-Counter (OTC) Rapid Test Product
8.2.1.2.	Professional Rapid Test Product
8.2.2.	By Application
8.2.2.1.	Infectious Disease
8.2.2.2.	Cardiology
8.2.2.3.	Oncology
8.2.2.4.	Pregnancy & Fertility
8.2.2.5.	Toxicology
8.2.2.6.	Glucose Monitoring
8.2.2.7.	Others
8.2.3.	By End-use
8.2.3.1.	Hospital & Clinic
8.2.3.2.	Diagnostic Laboratory
8.2.3.3.	Home Care
8.2.3.4.	Others
8.2.4.	By Country
8.2.4.1.	China
8.2.4.2.	India
8.2.4.3.	Japan
8.2.4.4.	Australia
8.2.4.5.	Rest of Asia Pacific
8.2.5.	Company Market Share (Top 3-5)
8.2.6.	Economic Impact Study on Asia Pacific Infectious Disease Rapid Diagnosis Testing Market 
9.	South America Infectious Disease Rapid Diagnosis Testing Market Overview
9.1.	South America Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2027
9.1.1.	Demand
9.1.1.1.	By Value (USD Million)
9.2.	South America Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2027
9.2.1.	By Product
9.2.1.1.	Over-the-Counter (OTC) Rapid Test Product
9.2.1.2.	Professional Rapid Test Product
9.2.2.	By Application
9.2.2.1.	Infectious Disease
9.2.2.2.	Cardiology
9.2.2.3.	Oncology
9.2.2.4.	Pregnancy & Fertility
9.2.2.5.	Toxicology
9.2.2.6.	Glucose Monitoring
9.2.2.7.	Others
9.2.3.	By End-use
9.2.3.1.	Hospital & Clinic
9.2.3.2.	Diagnostic Laboratory
9.2.3.3.	Home Care
9.2.3.4.	Others
9.2.4.	By Country
9.2.4.1.	Brazil
9.2.4.2.	Argentina
9.2.4.3.	Rest of South America
9.2.5.	Company Market Share (Top 3-5)
9.2.6.	Economic Impact Study on South America Infectious Disease Rapid Diagnosis Testing Market
10.	Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Overview
10.1.	Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Size & Forecast, 2016-2027
10.1.1.	Demand
10.1.1.1.	By Value (USD Million)
10.2.	Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market Share & Forecast, 2016-2027
10.2.1.	By Product
10.2.1.1.	Over-the-Counter (OTC) Rapid Test Product
10.2.1.2.	Professional Rapid Test Product
10.2.2.	By Application
10.2.2.1.	Infectious Disease
10.2.2.2.	Cardiology
10.2.2.3.	Oncology
10.2.2.4.	Pregnancy & Fertility
10.2.2.5.	Toxicology
10.2.2.6.	Glucose Monitoring
10.2.2.7.	Others
10.2.3.	By End-use
10.2.3.1.	Hospital & Clinic
10.2.3.2.	Diagnostic Laboratory
10.2.3.3.	Home Care
10.2.3.4.	Others
10.2.4.	By Country
10.2.4.1.	Saudi Arabia
10.2.4.2.	UAE
10.2.4.3.	South Africa
10.2.4.4.	Rest of Middle East & Africa
10.2.5.	Company Market Share (Top 3-5)
10.2.6.	Economic Impact Study on Middle East & Africa Infectious Disease Rapid Diagnosis Testing Market
11.	Competitor Analysis
11.1.	Company Description
11.2.	Financial Analysis
11.3.	Key Products
11.4.	Key Management Personnel 
11.5.	Contact Address
11.6.	SWOT Analysis
11.7.	Company Profile
11.7.1.1.	Abbott Laboratories
11.7.1.2.	Becton, Dickinson and Company
11.7.1.3.	Biomérieux SA
11.7.1.4.	Bio-Rad Laboratories
11.7.1.5.	 Danaher Corporation
11.7.1.6.	 Diasorin
11.7.1.7.	  Luminex
11.7.1.8.	  Meridian Bioscience
11.7.1.9.	  Quidel
11.7.1.10.	  Roche Diagnostics
11.7.1.11.	  Siemens AG
11.7.1.12.	  Thermo Fisher Scientific
11.7.1.13.	   Other players